譚仔國際(2217.HK)首日上市開盤破發
格隆匯10月7日丨譚仔國際(2217.HK)今日首日上市低開9.91%報3港元,市值40億港元。譚仔國際此次IPO定價3.33港元,公開發售獲29.58倍認購。譚仔國際是香港一家專營米線的知名連鎖餐廳營運商,所有餐廳均以兩個品牌自營,即“譚仔雲南米線”及“譚仔三哥米線”,在中國內地及新加坡亦擁有業務。截至2019年、2020年及2021年3月31日止年度,公司分別錄得收益15.56億港元、16.91億港元及17.95億港元,複合年增長率為7.4%。同期年度溢利分別為1.98億港元、1.91億港元及2.88億港元,複合年增長率為20.7%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.